Board Bomb 💣: Would You Miss This Depakote Red Flag? — Pearls and Prep

There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.”

Patients know the difference. Know the WHY!

Join our clinical library today on PATREON!

Today, we're diving into the wild world of pharmacokinetics with a case that's got more twists than a soap opera. Our star (MOCK) patient, Desiree, is dealing with bipolar disorder and some serious liver issues, which makes her Depakote treatment a real head-scratcher. The big question on the table is what to do when she's showing signs of toxicity, despite her Depakote levels being in the so-called therapeutic range. Spoiler alert: it’s not as cut and dry as it sounds! We’ll break down why those protein binding levels matter and why sometimes, the obvious answer might just lead you further down the rabbit hole. So grab your coffee, kick back, and let’s untangle this pharmacological puzzle together!

Board Bomb 💣: Would You Miss This Depakote Red Flag?

Pearls and Prep

pearlsandprep@mail.com

https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink

Let's dive into the juicy details of a case involving our fictional friend, Desiree, a 38-year-old with bipolar one disorder and some serious liver issues. Picture this: she’s on Depakote ER for her acute mania, but guess what? She's starting to feel more sedated than a couch potato on a lazy Sunday. With an albumin level of just 2.6, we’re talking about some potential trouble brewing in the pharmacy department. The question on everyone’s lips is: what do we do next? Do we bump up that Depakote dose, reassure the team, or maybe even add a benzodiazepine for that tremor? Spoiler alert: it’s all about understanding how protein binding works and how low albumin levels can throw a wrench in the works. Let’s break it down and keep our heads straight because this case has some high-yield learning moments that could make or break your practice. After all, we’re not just throwing darts in the dark here; we want to hit the bullseye with our clinical decisions!

Takeaways:

Today we dive deep into the world of pharmacokinetics, especially with Depakote and its protein binding.
Understanding albumin levels is crucial because low levels can lead to unexpected drug toxicity.
Don't just increase medication doses blindly; it could lead to more harm than good.
Always question the total drug levels in patients with liver issues before making changes.
Reassuring a team about therapeutic levels without addressing symptoms is like ignoring a fire in a car.
Being knowledgeable about your prescriptions can make you a top-notch provider that patients trust.

Links referenced in this episode:

Companies mentioned in this episode:

Depakote
Cymbalta
Carbamazepine

This podcast uses the following third-party services for analysis:

Podcorn - https://podcorn.com/privacy